Microbot Medical Inc. Operating Income Loss

• Microbot Medical Inc. showed a decrease of -26.8% in Operating Income Loss from 2024 to 2025.
• This data is from Microbot Medical Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
• XBRL data for this metric is available from 2009 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 18 years of available data (2009 to 2025), Microbot Medical Inc.'s Operating Income Loss has grown by 49.8%.
• Historical annual values: Fiscal year 2025: -$14.74 million | Fiscal year 2024: -$11.63 million | Fiscal year 2023: -$9.86 million | Fiscal year 2022: -$13.28 million | Fiscal year 2021: -$11.36 million | Fiscal year 2020: -$9.09 million | Fiscal year 2019: -$7.24 million | Fiscal year 2018: -$7.24 million | Fiscal year 2017: $5.27 million | Fiscal year 2016: -$9.64 million | Fiscal year 2015: $915.0 thousand | Fiscal year 2014: -$30.91 million | Fiscal year 2014: -$30.91 million | Fiscal year 2013: -$28.09 million | Fiscal year 2012: -$21.91 million | Fiscal year 2011: -$28.08 million | Fiscal year 2010: -$29.36 million | Fiscal year 2009: -$29.38 million.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026